Humacyte, Inc. is a biotechnology company based in Research Triangle Park, NC, specializing in regenerative medicine and tissue engineering. The company focuses on developing innovative human acellular vessels for use in various medical applications, including vascular surgery and organ transplantation. By leveraging advanced biomanufacturing techniques, Humacyte aims to address critical needs in the healthcare sector, enhancing patient outcomes through its pioneering technologies in vascular biology and regenerative therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

14 Patents

#1 in Research Triangle Park

#22,319 in New Caledonia

#42,249 in the World

Research Triangle Park, New Caledonia

Humacyte, Inc

Forward Citations = 31

21 inventors:

Laura E Niklason (13 out of 31 patents)

Justin T Strader (10 out of 12 patents)

Shannon L M Dahl (6 out of 6 patents)

4. William E Tente (6 out of 9 patents)

5. Joseph J Lundquist (6 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Humacyte, Inc. Retrieved from https://idiyas.com/company/humacyte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

10 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]